MHC class II antigen presentation pathway in murine tumours: Tumour evasion from immunosurveillance?

British Journal of Cancer

Volumn 83, Issue 9, 2000, Pages 1192-1201

  Walter, W ^a   Lingnau, K ^a   Schmitt, E ^a   Loos, M ^a   Maeurer, M J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigen processing; Gene regulation; MHC; Transcription factors

Indexed keywords

GAMMA INTERFERON; HLA DM ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; GENE CONTROL; IMMUNOSURVEILLANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TUMOR ESCAPE;

EID: 0033753861     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1415     Document Type: Article

References (40)

1. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation
2. Major histocompatibility complex class II-transfected tumour cells present endogenous antigen and are potent inducers of tumour-specific immunity
3. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments
4. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY)
5. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
6. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression
7. New class II-like genes in the murine MHC
8. Invariant chain structure and MHC class II function
9. Proteases, processing, and thymic selection
10. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules
11. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells
12. Crystal structure of mouse H2-M
13. Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays
14. Hemoglobins from bacteria to man: Evolution of different patterns of gene expression
15. Stability of patch methylation and its impact in regions of transcriptional initiation and elongation
16. A new human HLA class II-related locus, DM
17. Antigen loss variants of a murine renal cell carcinoma: Implications for tumour vaccination
18. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor
19. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments
20. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL- 12
21. Regulation of MHC class II genes: Lessons from a disease
22. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway
23. Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection
24. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
25. Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRIo thymocytes in vivo
26. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumours
27. The role of CD4+ T cell responses in antitumour immunity
28. Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci
29. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides
30. Association between HLA-DM and HLA-DR in vivo
31. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: Acquisition of antigen processing and presentation capacity
32. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5
33. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II
34. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH
35. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
36. H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove
37. H2-Mβ1 or H2-Mβ2 heterodimers equally promote CLIP removal in 1-A(q) molecules from autoimmune-prone DBA/1 mice
38. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region
39. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
40. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed